Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$2.63M Buy
98,036
+14,851
+18% +$397K 0.38% 61
2017
Q2
$2.14M Buy
83,185
+18,221
+28% +$464K 0.31% 89
2017
Q1
$1.67M Buy
64,964
+6,614
+11% +$169K 0.33% 79
2016
Q4
$1.48M Sell
58,350
-31,077
-35% -$737K 0.35% 63
2016
Q3
$2.12M Buy
89,427
+15,724
+21% +$395K 0.45% 23
2016
Q2
$1.91M Buy
73,703
+19,010
+35% +$470K 0.46% 19
2016
Q1
$1.4M Buy
54,693
+1,487
+3% +$33.3K 0.37% 56
2015
Q4
$1.05M Buy
53,206
+43,877
+470% +$889K 0.3% 92
2015
Q3
$198K Sell
9,329
-96,101
-91% -$2.16M 0.05% 505
2015
Q2
$2.36M Sell
105,430
-7,508
-7% -$180K 0.3% 138
2015
Q1
$2.71M Sell
112,938
-1,695
-1% -$42K 0.37% 102
2014
Q4
$3.03M Buy
+114,633
New +$2.94M 0.62% 23

Other funds holding EXC

GAM Systematic's EXC Position: Q3 2017 in Review

GAM Systematic increased its Exelon (EXC) stake by 18% in Q3 2017, buying an estimated $397K and bringing the position to 98,036 shares worth $2.63M. The position accounts for 0.38% of the portfolio, ranked #61.

GAM Systematic first reported a position in EXC in Q4 2014 and has held it in 12 quarters since. The position peaked at $3.03M in Q4 2014. 781 funds tracked by Wall St. Rank hold EXC as of Q3 2017.

  • GAM Systematic held 98,036 shares of Exelon worth $2.63M as of Q3 2017.
  • GAM Systematic bought 14,851 Exelon shares in Q3 2017, an estimated $397K.
  • Exelon made up 0.38% of GAM Systematic's portfolio in Q3 2017, its #61 holding.
  • GAM Systematic first reported a position in Exelon in Q4 2014 and has held it in 12 quarters since.
  • GAM Systematic's Exelon position peaked at $3.03M in Q4 2014.
  • 781 funds tracked by Wall St. Rank held Exelon as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.